Tech Company Financing Transactions
Helex Funding Round
Pi Ventures, BlueHill Asset Management and SOSV participated in a $3.5 million Seed venture round for Helex. This VC investment round was announced by the company on 10/30/2025.
Transaction Overview
Company Name
Announced On
10/30/2025
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds for the development of its lead program for ADPKD toward IND enabling studies, pipeline expansion leveraging its programmable LNP delivery and AI-based drug design platforms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
We are building Helex with a mission to serve all patients with a high unmet need in an accessible and affordable manner. All our work is driven by our users - the patients and their families. At Helex, we wish to build more than a business, we wish to build an institution that advances science, technology, and human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Poulami Chaudhuri
Chief Operating Officer
Anirudh Nishtala
VP - Bus. Development
Rohini Kalvakuntla
Browse more venture capital transactions:
Prev: 10/30/2025: Catalyx Space venture capital transaction
Next: 10/30/2025: KapKap venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs